Skip to content

Clinical Study to Evaluate the Efficacy and Safety of Ved Sanjeevani Snore Off Nabhi Oil in Adults with Habitual Snoring and Sleep-Disordered Breathing (Kaphaja Shwasa Dushti / Nidra Vikara)

A Single-Arm OpenLabel Clinical Study to Evaluate the Efficacy and Safety of Ved Sanjeevani Snore Off Nabhi Oil in Adults with Habitual Snoring and Sleep-Disordered Breathing Kaphaja Shwasa Dushti Nidra Vikara Assessment of Snoring Frequency Sleep Quality and Nasal Airway Patency - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/111898
Enrollment
60
Registered
2026-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders Health Condition 2: J989- Respiratory disorder, unspecified

Interventions

None listed

Sponsors

VRD SANJEEVANI PRIVATE LIMITED
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adults of either sex aged 18 to 65 years inclusive 2 Habitual snoring 3 nights week for 1 month confirmed by self report and or bed partner report 3 PSQI total score 5 at baseline indicating poor sleep quality 4 Ayurvedic diagnosis of Kaphaja Shwasa Dushti or Nidra Vikara established by a qualified Kayachikitsa clinician 5 Willingness to maintain a daily sleep diary throughout the study period 6 Availability of a bed partner household member able to provide snoring frequency and loudness assessment at each visit 7 Freely willing to provide written informed consent in English Hindi or Marathi 8 Agreement to refrain from any other topical aromatic or nasal decongestant product sprays strips ointments during the study 9 Agreement to adhere to standard sleep hygiene advice provided at enrollment 10 ESS score 7 significant daytime sleepiness OR partner confirmed snoring causing significant sleep disturbance 11 BMI 18 5 and 35 kgm

Exclusion criteria

Exclusion criteria: 12 Confirmed severe obstructive sleep apnea OSA with AHI 30hr on polysomnography or home sleep test currently prescribed CPAP therapy Mild-to moderate OSA AHI 5-29 is NOT an exclusion these subjects represent the clinically relevant target population 13 Known hypersensitivity or allergy to any formulation component sesame oil coconut oil castor oil mustard oil Eucalyptus Camphor Peppermint Thyme Lavender Frankincense EOs Vasa Adhatoda vasica Tulsi Tagar Jatamansi Mulethi Ajwain Cinnamon or Black Pepper 14 Active skin conditions at Nabhi site contact dermatitis eczema active rash umbilical hernia abdominal wall infection or surgical scar 15 Pregnant women or lactating mothers 16 Current use of prescribed sedative hypnotic medications benzodiazepines Z drugs zolpidem zopiclone or opioid analgesics 17 Uncontrolled systemic illness active malignancy severe cardiac disease NYHA Grade III IV uncontrolled hypertension uncontrolled diabetes 18 Acute upper respiratory tract infection or sinusitis within the preceding 2 weeks rescreen after resolution 19 Confirmed nasal polyps deviated nasal septum requiring surgical correction or laryngeal structural abnormality as the sole mechanical cause of snoring 20 Significant hepatic disease 21 Participation in another interventional clinical trial within the preceding 3 months 22 Subjects living alone without any bedpartner or household member who can assess snoring snoring frequency secondary endpoint requires an informant 23 Inability or unwillingness to attend all 5 assessment visits or complete daily sleep diary

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index PSQITimepoint: BASE LINE DAY 10 DAY 20 DAY 30 DAY FU 60

Secondary

MeasureTime frame
Snoring Frequency Self Reported & Bed PartnerReported VAS Snoring Severity Epworth Sleepiness Scale Berlin QuestionnaireTimepoint: BASE LINE DAY 10 DAY 20 DAY 30 DAY FU 60

Countries

India

Contacts

Public ContactDr Pawan Lekurwale

L N Ayurved College and Hospital Bhopal

pawanayu2013@gmail.com9579766005

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026